Skip to main content
. 2023 Nov 30;14:1257085. doi: 10.3389/fimmu.2023.1257085

Figure 3.

Figure 3

Serum levels of CCL8, CXCL13, and IL-1RA in patients with SLE, patients with other autoimmune diseases (AIDs), and healthy controls (HC). Violin plots displaying distributions of circulating levels of CCL8 (A-C), CXCL13 (D-F), and IL-1RA (G-I) in patients with active versus inactive SLE versus HC (A, D, G), patients with SLE versus patients with AID versus HC (B, E, H), and patients with SLE versus patients with primary antiphospholipid syndrome (pAPS) versus HC (C, F, I). (J) Spearman’s rank correlations between levels of CCL8, CXCL13, and IL-1RA. Statistically significant correlations are denoted by asterisks. AID: autoimmune disease; CCL8; C-C motif chemokine ligand 8; CXCL13: C-X-C motif ligand 13: IL-1RA: interleukin 1 receptor antagonist; pAPS: primary antiphospholipid syndrome; SLE: systemic lupus erythematosus.